![BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND | Business Wire BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND | Business Wire](https://mms.businesswire.com/media/20230525005591/en/1803558/23/BenchSci_Logo_Horizontal_Dark.jpg)
BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND | Business Wire
![BenchSci expands scientists' access to critical experimental insights with addition of top journals from Taylor & Francis - Taylor & Francis Newsroom BenchSci expands scientists' access to critical experimental insights with addition of top journals from Taylor & Francis - Taylor & Francis Newsroom](https://newsroom.taylorandfrancisgroup.com/wp-content/uploads/2020/11/Logo2020_Transparent_RGB.png)
BenchSci expands scientists' access to critical experimental insights with addition of top journals from Taylor & Francis - Taylor & Francis Newsroom
![BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND | Generation Investment Management BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND | Generation Investment Management](https://www.generationim.com/media/dpyd40j0/benchsci_logo_genim.png)